Frank Yocca - Chief Scientific Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
BTAI on Nasdaq
All Insider Reports
All Insider Reports

Frank Yocca - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Frank Yocca for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28.9K $10.2K $0.35 Dec 16, 2024 Direct
Restricted Stock Units 5.06K $2.79K $0.55 Dec 15, 2024 Direct Common Stock
Stock Option (right to buy) 270K Jan 7, 2025 Direct Common Stock

Transactions reported by Frank Yocca for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.